Skip to content
Lower risk Drug recall · FDA · Published December 6, 2021

NaturesPlus Joint Cream Recall: Microbial Contamination Risk

NaturesPlus recalls 4 oz glucosamine chondroitin MSM joint cream due to microbial contamination. Stop using if you have the product with lot #23622.

🇺🇸 FDA recall #D-0559-2022DrugNaturesPlus ›
Take action

Contact the company

Recalling firmOrganics Corporation of America DBA Ambix Laboratories55 W End Rd · Totowa, NJ 07512-1405
✎ GovInfoNow plain-language explainer

NaturesPlus is recalling its Glucosamine Chondroitin MSM Ultra Rx- Joint Cream because it was contaminated with Pluralibacter gergoviae bacteria. This contamination could cause health issues if the product is used. Read more at govinfonow.com/recall/35470-naturesplus-joint-cream-recall-microbial-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/35470-naturesplus-joint-cream-recall-microbial-contamination-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0559-2022

Cite this page

“NaturesPlus Joint Cream Recall: Microbial Contamination Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35470-naturesplus-joint-cream-recall-microbial-contamination-risk. Based on FDA recall #D-0559-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0559-2022%22&limit=1).

The FDA announced on Dec. 6, 2021, that Organics Corporation of America DBA Ambix Laboratories voluntarily recalled NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream due to microbial contamination. The product contains Pluralibacter gergoviae.

How to tell if you have it

  • Brand: NaturesPlus
  • Product: Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream, 4 oz tubes
  • Lot #: 23622
  • Product code: 4929
  • Quantity: 4,214 tubes

The hazard

The recall involves microbial contamination of the non-sterile product, specifically a contaminant identified as Pluralibacter gergoviae. The FDA classified this as a Class II recall.

Context

Other recent recalls of similar products include Blaine Labs Revitaderm Wound Gel (2026-04-08) and Wisconsin Pharmacal MG217 Cream (2026-04-24).

How to tell if you have this one

Check for 4 oz tubes labeled 'NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream' with lot number 23622. The product was manufactured for NaturesPlus at 548 Broadhollow Road, Melville, NY.

  • Brand
    NaturesPlus
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the product code 4929 and lot number 23622 on the tube.

Where it went and when

Where it was distributed

Distributed in New York.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “The product went to one consignee. Natural Organics, Inc., 548 Broadhollow Rd., Melville, NY 11747.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New York.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Dec 6, 202112. FDA classified it Class II: Feb 14, 202223. Published in FDA’s Enforcement Report: Feb 23, 2022320212022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0559-2022 (December 6, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0559-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA